- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0054728

About Medo Specia Laboratories Private Limited
Data last updated:
Medo Specia Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the advertising and media services segment of the media and publishing sector. It was incorporated on 27 August 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24200MH1999PTC121496. Its GSTIN is 27AAACD9858L1Z0 (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹25.14 Lakh. It was formerly known as Doc-N- Cliq Labs Private Limited. It is led by directors Krishna Prasad Balasubramanian and Ashwin Prasad.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 101 Ghatkopar Industrial Estate L.B.S. Marg Ghatkopar (West), Mumbai, Maharashtra, India – 400086.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.76 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹3.1 Cr (net margin 26.4%) and EBITDA of ₹3.4 Cr (EBITDA margin 28.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 44% over five years.
The company is associated with 2 brands: Medo Specia and Tidal Healthcare. As per MCA filings, the company has open charges of ₹10 Lakh on record.
Medo Specia Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0054728). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tidalhealthcare.com.
Company details
Recognitions & Rankings of Medo Specia Laboratories
Contact details
Medo Specia Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is tidalhealthcare.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressA – 101 Ghatkopar Industrial Estate L.B.S. Marg Ghatkopar (West), Mumbai, Maharashtra, India – 400086
- IndustryMedia and Publishing, Advertising Agencies & Media Services
To see the full contact details of Medo Specia Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Medo Specia Laboratories operates two associated brands: Medo Specia and Tidal Healthcare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers online sales of hygiene, wellness, and nutrition products directly to consumers. | medospecia.in | |
| Formulations marketing company providing innovative health solutions in pharmaceuticals. | tidalhealthcare.com |
Business activity
The main business activities of Medo Specia Laboratories are trade and support service to organizations. In detail, this covers wholesale trading and other support services to organizations. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Medo Specia Laboratories Private Limited, buy the company report.
Financials of Medo Specia Laboratories Private Limited
FY 2025 filings availableMedo Specia Laboratories Private Limited reported revenue of ₹11.76 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 44% over five years, including 7% growth in the latest year. EBITDA rose 271% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 28.9% | ||||
| Net Profit Margin | 26.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medo Specia Laboratories Private Limited, buy the company report.
Board of directors of Medo Specia Laboratories Private Limited
Medo Specia Laboratories has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Prasad Balasubramanian | Director | 03 Aug 2009 | 17 Years 2 Months | Current |
| Ashwin Prasad Also directs: Tidal Healthcare Private Limited | Director | 27 Jul 2016 | 10 Years 3 Months | Current |
Peer comparison
Medo Specia Laboratories Private Limited is compared with the 3 companies closest to it by revenue in the FMCG industry (Personal Care and Skin Care), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brand Nourish Private Limited | ₹11.79 Cr (FY 2025) | -83.0% | Kolkata, West Bengal, India | |||
| Albus Healthcare Private Limited | ₹11.78 Cr (FY 2025) | 22.0% | Jaipur, Rajasthan, India | |||
| Medo Specia Laboratories Private Limitedthis company | ₹11.76 Cr (FY 2025) | ₹3.1 Cr | 26.4% | 7.0% | Mumbai, Maharashtra, India | |
| Capital Office Suppliers Private Limited | ₹11.68 Cr (FY 2025) | 30.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Medo Specia Laboratories Private Limited, buy the company report.
Auditor
Medo Specia Laboratories Private Limited is audited by K A R M & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K A R M & CO | FY 2021 | 105237W |
Shareholding
The shareholding of Medo Specia Laboratories Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medo Specia Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Feb 2000 | 90157422 | Central Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medo Specia Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medo Specia Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medo Specia Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACD9858L1Z0 | Maharashtra | Active | 07 Jun 2019 |
To see the full GST registrations and return filing status of Medo Specia Laboratories Private Limited, buy the company report.
Recent activity
Medo Specia Laboratories Private Limited has 5 board changes on record since 2009: 2 appointments and 3 cessations. The latest: Ashwin Prasad ceased to be Additional Director on 29 Sep 2016.
Frequently asked questions
Medo Specia Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in advertising agencies and media services, within the media and publishing industry. It was incorporated on 27 August 1999 (27+ years old) and is registered under CIN U24200MH1999PTC121496.
Medo Specia Laboratories has 2 current directors:
- Krishna Prasad Balasubramanian - Director
- Ashwin Prasad - Director
The latest financial statements of Medo Specia Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medo Specia Laboratories is 27AAACD9858L1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medo Specia Laboratories is U24200MH1999PTC121496. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medo Specia Laboratories was incorporated on 27 August 1999, making it 27+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medo Specia Laboratories by revenue are Brand Nourish Private Limited, Albus Healthcare Private Limited, Capital Office Suppliers Private Limited, all in the FMCG industry (Personal Care and Skin Care), with the same principal business activity (wholesale trading).
Ashwin Prasad ceased to be Additional Director on 29 Sep 2016. Ashwin Prasad was appointed as Director on 27 Jul 2016. Balasubramanian Anantharaman ceased to be Director on 27 Jul 2016. Medo Specia Laboratories has 5 board changes on record in total.
Yes, Medo Specia Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0054728).
Medo Specia Laboratories can be reached through the website tidalhealthcare.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Medo Specia Laboratories is at A – 101 Ghatkopar Industrial Estate L.B.S. Marg Ghatkopar West, Mumbai, Maharashtra, India – 400086.

